LDL Lowering in Peripheral Arterial Disease: Are There Benefits Beyond Reducing Cardiovascular Morbidity and Mortality?

Overview

Journal Clin Lipidol

Date 2012 Jun 19

PMID 22707981

Citations 3

Authors

Amy W Pollak

Christopher M Kramer

Affiliations

Soon will be listed here.

Abstract

Peripheral arterial disease affecting the lower extremities is associated with increased mortality due to cardiovascular events and reduced functional capacity due to claudication. There is abundant evidence to support the role of lipid lowering with statins in preventing cardiovascular events in patients with peripheral arterial disease. Over the last 10 years, multiple studies have been designed to test the theory that LDL C lowering with statins could result in improved exercise performance in patients with peripheral arterial disease. However, this remains an active area of investigation to better understand how the pleiotropic effects of statins could lead to enhanced functional capacity for patients with claudication. Furthermore, new insights into the complex pathophysiology of claudication may help us to understand the potential role of lipid lowering therapy in alleviating exercise induced symptoms.

Citing Articles

Sex and Racial Disparities in Peripheral Artery Disease.

Divakaran S, Krawisz A, Secemsky E, Kant S Arterioscler Thromb Vasc Biol. 2023; 43(11):2099-2114.

PMID: 37706319 PMC: 10615869. DOI: 10.1161/ATVBAHA.123.319399.

Impact of novel microbial secondary metabolites on the pharma industry.

Ramirez-Rendon D, Passari A, Ruiz-Villafan B, Rodriguez-Sanoja R, Sanchez S, Demain A Appl Microbiol Biotechnol. 2022; 106(5-6):1855-1878.

PMID: 35188588 PMC: 8860141. DOI: 10.1007/s00253-022-11821-5.

Risk and Benefits of Statins in Glucose Control Management of Type II Diabetes.

Sunjaya A, Sunjaya A, Halim S, Ferdinal F Int J Angiol. 2018; 27(3):121-131.

PMID: 30154630 PMC: 6103774. DOI: 10.1055/s-0036-1572523.

References

Balk E, Karas R, Jordan H, Kupelnick B, Chew P, Lau J . Effects of statins on vascular structure and function: a systematic review. Am J Med. 2004; 117(10):775-90. DOI: 10.1016/j.amjmed.2004.05.026. View

Taylor A, Sullenberger L, Lee H, Lee J, Grace K . Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: a double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with.... Circulation. 2004; 110(23):3512-7. DOI: 10.1161/01.CIR.0000148955.19792.8D. View

Volpato S, Vigna G, McDermott M, Cavalieri M, Maraldi C, Lauretani F . Lipoprotein(a), inflammation, and peripheral arterial disease in a community-based sample of older men and women (the InCHIANTI study). Am J Cardiol. 2010; 105(12):1825-30. PMC: 2888047. DOI: 10.1016/j.amjcard.2010.01.370. View

Kinlay S, Plutzky J . Effect of lipid-lowering therapy on vasomotion and endothelial function. Curr Cardiol Rep. 2000; 1(3):238-43. DOI: 10.1007/s11886-999-0029-5. View

Mondillo S, Ballo P, Barbati R, Guerrini F, Ammaturo T, Agricola E . Effects of simvastatin on walking performance and symptoms of intermittent claudication in hypercholesterolemic patients with peripheral vascular disease. Am J Med. 2003; 114(5):359-64. DOI: 10.1016/s0002-9343(03)00010-x. View

Lindner J, Womack L, Barrett E, Weltman J, Price W, Harthun N . Limb stress-rest perfusion imaging with contrast ultrasound for the assessment of peripheral arterial disease severity. JACC Cardiovasc Imaging. 2009; 1(3):343-50. PMC: 2651026. DOI: 10.1016/j.jcmg.2008.04.001. View

Weitz J, Byrne J, Clagett G, Farkouh M, Porter J, Sackett D . Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. Circulation. 1996; 94(11):3026-49. DOI: 10.1161/01.cir.94.11.3026. View

. Peripheral arterial disease in people with diabetes. Diabetes Care. 2003; 26(12):3333-41. DOI: 10.2337/diacare.26.12.3333. View

Pipinos I, Judge A, Selsby J, Zhu Z, Swanson S, Nella A . The myopathy of peripheral arterial occlusive disease: Part 2. Oxidative stress, neuropathy, and shift in muscle fiber type. Vasc Endovascular Surg. 2008; 42(2):101-12. DOI: 10.1177/1538574408315995. View

10.

Marso S, Hiatt W . Peripheral arterial disease in patients with diabetes. J Am Coll Cardiol. 2006; 47(5):921-9. DOI: 10.1016/j.jacc.2005.09.065. View

11.

Kastelein J, Akdim F, Stroes E, Zwinderman A, Bots M, Stalenhoef A . Simvastatin with or without ezetimibe in familial hypercholesterolemia. N Engl J Med. 2008; 358(14):1431-43. DOI: 10.1056/NEJMoa0800742. View

12.

Muluk S, Muluk V, Kelley M, Whittle J, Tierney J, Webster M . Outcome events in patients with claudication: a 15-year study in 2777 patients. J Vasc Surg. 2001; 33(2):251-7; discussion 257-8. DOI: 10.1067/mva.2001.112210. View

13.

Rizzo M, Pernice V, Frasheri A, Berneis K . Atherogenic lipoprotein phenotype and LDL size and subclasses in patients with peripheral arterial disease. Atherosclerosis. 2007; 197(1):237-41. DOI: 10.1016/j.atherosclerosis.2007.03.034. View

14.

. Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions. J Vasc Surg. 2007; 45(4):645-654. DOI: 10.1016/j.jvs.2006.12.054. View

15.

Selvin E, Erlinger T . Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation. 2004; 110(6):738-43. DOI: 10.1161/01.CIR.0000137913.26087.F0. View

16.

Laufs U, La Fata V, Plutzky J, Liao J . Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation. 1998; 97(12):1129-35. DOI: 10.1161/01.cir.97.12.1129. View

17.

Giri J, McDermott M, Greenland P, Guralnik J, Criqui M, Liu K . Statin use and functional decline in patients with and without peripheral arterial disease. J Am Coll Cardiol. 2006; 47(5):998-1004. DOI: 10.1016/j.jacc.2005.10.052. View

18.

Meade T, Zuhrie R, Cook C, Cooper J . Bezafibrate in men with lower extremity arterial disease: randomised controlled trial. BMJ. 2002; 325(7373):1139. PMC: 133451. DOI: 10.1136/bmj.325.7373.1139. View

19.

Van Belle E, Rivard A, Chen D, Silver M, Bunting S, Ferrara N . Hypercholesterolemia attenuates angiogenesis but does not preclude augmentation by angiogenic cytokines. Circulation. 1997; 96(8):2667-74. DOI: 10.1161/01.cir.96.8.2667. View

20.

Schillinger M, Exner M, Mlekusch W, Amighi J, Sabeti S, Muellner M . Statin therapy improves cardiovascular outcome of patients with peripheral artery disease. Eur Heart J. 2004; 25(9):742-8. DOI: 10.1016/j.ehj.2004.02.012. View